ABSCI CORP (ABSI)
(Delayed Data from NSDQ)
$2.91 USD
-0.04 (-1.36%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.91 0.00 (0.00%) 7:04 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Absci Corporation's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ABSI 2.91 -0.04(-1.36%)
Will ABSI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ABSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABSI
Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy?
Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates
ABSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains?
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
Other News for ABSI
Vanguard Group Inc's Strategic Acquisition of Absci Corp Shares
Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on ...
Insider Buying: Andreas Busch Acquires 50,000 Shares of Absci Corp (ABSI)
Absci (ABSI) Receives Price Target Adjustment by Morgan Stanley | ABSI Stock News
Absci (ABSI) Price Target Reduced by Morgan Stanley Amid Public Offering